Very early neurological deterioration after thrombolysis in patients with acute ischemic stroke

Ying-Chi Shen; Shin-Joe Yeh; Chih-Hao Chen; Sung-Chun Tang; Li-Kai Tsai; Jiann-Shing Jeng

doi:10.1101/2023.03.05.23286824

Abstract

Background Early neurological deterioration within 24 h after thrombolysis in patients with acute ischemic stroke (AIS) is associated with poor outcomes. Evidence is lacking regarding neurological deterioration within 1 h after thrombolysis.

Methods Patients who received intravenous thrombolysis with tissue plasminogen activator (tPA) for AIS between January 2018 and December 2021 were consecutively enrolled. Very early neurological deterioration (VEND) was defined as a ≥ 4-point increase in the National Institutes of Health Stroke Scale (NIHSS) score within 1 h after starting thrombolysis compared with the pre-treatment score. A modified Rankin Scale score of 3–6 at 3 months was defined as a poor functional outcome.

Results Of the 353 AIS patients (age 69.7 ± 13.3 years, 57% men) receiving thrombolysis with tPA, 29 (8.4%) had VEND. VEND was associated with symptomatic intracranial atherosclerotic disease (ICAD) (41% vs. 17%, P = 0.005) and was an independent predictor of poor functional outcomes at 3 months (adjusted odds ratio 3.04, P = 0.043). The VEND group had higher NIHSS scores at 1 h (19.2 ± 7.3 vs. 9.0 ± 7.1, P < 0.001) and 24 h (14.1 ± 9.8 vs. 7.3 ± 7.5, P = 0.001) after initiating tPA than the non-VEND group. In patients with an initial NIHSS score < 6, VEND was significantly associated with ICAD, receiving endovascular thrombectomy (EVT), and poor functional outcomes. In patients with VEND, EVT with successful recanalization led to lower NIHSS scores at 24 h than in those without successful recanalization (12 ± 9 vs. 26 ± 7, P = 0.047), and 24-h NIHSS scores predicted poor functional outcomes.

Conclusions In patients receiving thrombolysis, VEND was independently associated with poor functional outcomes. Identifying VEND is crucial for underlying ICAD and salvageability by EVT. Successful recanalization by EVT effectively reduced 24-h stroke severity in patients with VEND.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study received grant from National Taiwan University Hospital (111-S0222).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data for this study were retrieved from the National Taiwan University Hospital Stroke Registry initiated in 1995, which was approved by the Institutional Review Board of this tertiary referral and teaching hospital (No. 9561703056). All participants or their next of kin provided written informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable